GID BIO, Inc.

LOUISVILLE, CO · Founded 2008 · Biotech · Private

Stromal Vascular Fraction (SVF) cell injection therapy for knee osteoarthritis

Claim this profile

Follows are private to you and power your alerts

Updated · gidbio.com

Sector
Biotech
Headquarters
LOUISVILLE, CO
Founded
2008
Latest Form D
$5.3M, Jan 2022
Total capital
$12.7M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$12.7M
4 Form D · last Jan 2022
58 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
8
6 pending · first 2021
Rank in peer group#196 of 1449

Capital timeline

2010201220142016201820202022FEDERAL ↑EQUITY ↓Cumulative $12.7M3rd Form D$2.2M4th Form D$5.3M
2010201420182022FEDERAL ↑EQUITY ↓Cumulative $12.7M4th Form D$5.3M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$5.3M
  • Private capital raisedForm D · SEC · 3rd filing$2.2M
  • Private capital raisedForm D · SEC · 2nd filing$2.7M
  • Private capital raisedForm D · SEC · 1st filing$2.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#196 · top 14%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • William CiminoResearcherExecutive Officer, DirectorLinked by 8 patents
  • Adam S. KatzDirectorNamed in SEC Form D filings
  • David S. SmithExecutive OfficerNamed in SEC Form D filings
  • John S. MarousDirectorNamed in SEC Form D filings
  • Morgan S. St. JohnDirectorNamed in SEC Form D filings
  • Nicholas S. PachudaDirectorNamed in SEC Form D filings
Show all 8 people
  • Roy S. BostockDirectorNamed in SEC Form D filings
  • William S. FutrellDirectorNamed in SEC Form D filings

What it has protected

USPTO · 8 granted of 14
  • PendingDevice For Processing TissueUSPTOApplication 19252961
  • PendingTissue Processing Apparatus And Method For Processing Adipose TissueUSPTOApplication 19183999
  • PendingAdipose Tissue Processing MethodUSPTOApplication 19084527
Show all 14 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .